Accelerate patient enrollment, ensure strict UDI traceability, and guarantee Notified Body approval with a specialized clinical site management team operating across Europe and Japan.
Request Site Feasibility AssessmentUnder the strict framework of the EU MDR 2017/745, generating robust clinical data is no longer optional—it is the absolute foundation of your market access strategy. Executing a clinical investigation flawlessly across multiple hospitals requires a highly specialized approach.
End-to-End SMO Services for MedTech
Executing a clinical investigation across multiple hospitals requires more than generic monitoring. As a leading smo clinical trials europe partner, we manage the entire site lifecycle to guarantee compliance and speed.
Site Selection
Rigorous site selection medical device eu mdr assessments to identify KOLs with the exact surgical and technical expertise required for your device class.
Regulatory Submissions
Rapid localized submissions to Ethics Committees (e.g., CPP in France, IRB in the UK) and Competent Authorities to minimize critical start-up delays.
Patient Recruitment
Proactive screening and dedicated site coordination to accelerate enrollment, ensuring your clinical milestones are met strictly on schedule.
ISO 14155 Monitoring
Meticulous Site Initiation (SIV), Interim Monitoring (IMV), and Close-Out Visits (COV) to guarantee pristine source data verification against the EDC.
Why MedTech Site Management is Radically Different
A common failure point for sponsors is hiring a generic pharma CRO to run a medical device trial. Clinical site management eu mdr operates under fundamentally different mechanics that demand specialized oversight.
| Regulatory & Clinical Metric | Pharmaceutical Trials (Standard GCP) | Medical Device Trials (ISO 14155 / EU MDR) |
|---|---|---|
| Investigator Dependency | Drug efficacy is largely independent of the physician administering the pill. | Device performance is directly tied to the surgeon's skill. Surgical learning curves must be monitored and statistically accounted for. |
| Product Traceability | Standard batch tracking at the pharmacy level. | Strict EU MDR Article 27 compliance. CRAs must verify exact UDI-DI/PI logs, device accountability, and implant cards at the site level. |
| Vigilance & Reporting | Adverse Events (AE) and Serious Adverse Events (SAE). | Mandatory tracking of Device Deficiencies (DD), SADE, and ASADE. A device failure that did not harm the patient must still be rigorously reported. |
| Endpoints & Usability | Pharmacokinetics and systemic physiological markers. | Complex per-operative metrics (e.g., procedural time, ergonomics) requiring CRAs who understand the surgical workflow and IEC 62366-1 usability standards. |
Our Geographic Footprint
Clinical practices, standard of care, and ethics committee regulations vary wildly across borders. We deploy deeply embedded, in-house CRAs across key global markets to ensure rapid site activation.
Therapeutic Vertical Expertise
Site management medical device trials require CRAs who understand the specific clinical and surgical environment of your device class.
Cardiovascular
Managing high-risk Class III implantables, TAVR/TAVI procedures, and navigating complex VARC-3 endpoint criteria in specialized cath labs.
Orthopaedics
Site management for joint replacements and spinal implants, integrating seamlessly with long-term registry data capture (e.g., NJR, EPRD).
Wound Care
Executing PMCF and clinical investigations for advanced wound matrices, managing complex healing trajectory tracking per EWMA guidelines.
Frequently Asked Questions
Why is site management different for medical device clinical trials?
How does EU MDR 2017/745 affect clinical site management?
Which countries do Eclevar's SMO services cover?
Ready to Activate Your Clinical Sites?
Ensure your next clinical investigation is placed with the right investigators in the right European countries. Contact our Clinical Operations team for a rapid evaluation.
Request Site Feasibility Assessment